alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › foe

foe

2 studies tagged foe, dated 2019-12-10 to 2022-06-14. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Microglia: Friend and foe in tauopathy 2022-06-14
  2. Friend, Foe or Both? Immune Activity in Alzheimer's Disease 2019-12-10

Studies

2 studies carry this tag.

Date range

2019 to 2022

Top journals

  • Frontiers in aging neuroscience 1
  • Progress in neurobiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Microglia: Friend and foe in tauopathy

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Progress in neurobiology 2022-06-14 Drug development

    Aggregation of misfolded microtubule associated protein tau into abnormal intracellular inclusions defines a class of neurodegenerative diseases known as tauopathies.

  2. Friend, Foe or Both? Immune Activity in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in aging neuroscience 2019-12-10 Genetics

    Alzheimer's disease (AD) is marked by the presence of amyloid beta (Aβ) plaques, neurofibrillary tangles (NFT), neuronal death and synaptic loss, and inflammation in the brain.

All topic tags with their study counts